|

VACl Alternating With VACh Clinical Trials

1 actively recruiting trial

Also known as: Venetoclax+Azacitidine+Cladribine alternating with Venetoclax+Azacitidine+Chidamide

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Soochow University1

Indications

  • Newly Diagnosed1
  • Acute Myeloid Leukemia, Adult1
  • Cancer1

Other1 trial

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.